 PRINCETON, N.J., Nov. 09, 2021 GLOBE NEWSWIRE -- Oyster Point Pharma, Inc. Nasdaq: OYST, a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases, today announced multiple scientific presentations at the American Academy of Ophthalmology AAO Annual Meeting 2021 being held in New Orleans, LA November 12th 15th, 2021. 